Vestibular Diseases Clinical Trial
Official title:
2BALANCE: The Impact of a Vestibular Dysfunction on Cognitive and Motor Performance in Adults in Single and Dual-task Condition
| NCT number | NCT04126798 |
| Other study ID # | BC-7935 |
| Secondary ID | |
| Status | Completed |
| Phase | |
| First received | |
| Last updated | |
| Start date | August 12, 2019 |
| Est. completion date | June 15, 2023 |
| Verified date | September 2023 |
| Source | University Hospital, Ghent |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
The overall aim of this study is to elucidate the impact of a vestibular dysfunction on the cognitive and motor performance by means of an extensive test protocol, evaluating the vestibular, cognitive and motor function using single as well as dual-task paradigms.
| Status | Completed |
| Enrollment | 130 |
| Est. completion date | June 15, 2023 |
| Est. primary completion date | April 15, 2023 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years to 65 Years |
| Eligibility | For healthy controls: Exclusion Criteria: - Vestibular disorders or subjective dizziness complains (past or present) - Hearing loss - Mild Cognitive Impairment (Montreal Cognitive Assessment, MOCA) - Visual impairment (Snellen Chart) - Motor abnormalities (anamnestic questionnaire) For bilateral vestibulopathy (BV): Inclusion criteria: - Bilaterally reduced vestibular function, as defined by the Bárány Criteria for BV(Michael Strupp 2017): - the horizontal vestibulo-ocular reflex (VOR) gain should be <0.6 bilaterally and/or - the sum of the maximal peak velocities of caloric response for stimulation with warm and cold water should be <6?/s bilaterally and/or - the horizontal angular VOR gain should be <0.1 upon sinusoidal stimulation on the rotation test For unilateral vestibulopathy: Inclusion criteria: - the horizontal VOR gain should be <0.6 unilaterally and/or - the slow component velocity of the caloric response should be below the age-dependent normative data unilaterally, established by Maes et al. (2010) |
| Country | Name | City | State |
|---|---|---|---|
| Belgium | University Hospital Ghent, departement otorhinolaryngology | Ghent |
| Lead Sponsor | Collaborator |
|---|---|
| University Hospital, Ghent | Maastricht University Medical Center, Universiteit Antwerpen, University Ghent |
Belgium,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Stride length measured on the GAITRite Walkway (ProCare) | Stride length measured in centimeters on pressure sensitive mat | 4 years | |
| Primary | Step length measured on the GAITRite Walkway (ProCare) | Step length measured in centimeters on pressure sensitive mat | 4 years | |
| Primary | Stride width measured on the GAITRite Walkway (ProCare) | Stride width measured in centimeters on pressure sensitive mat | 4 years | |
| Primary | Step width measured on the GAITRite Walkway (ProCare) | Step width measured in centimeters on pressure sensitive mat | 4 years | |
| Primary | Step time measured on the GAITRite Walkway (ProCare) | Step time measured in seconds on pressure sensitive mat | 4 years | |
| Primary | Stride time measured on the GAITRite Walkway (ProCare) | Stride time measured in seconds on pressure sensitive mat | 4 years | |
| Primary | Velocity measured on the GAITRite Walkway (ProCare) | Velocity measured in centimeters per second on pressure sensitive mat | 4 years | |
| Primary | Surface (mm²) of the confidence ellipse which contains 90% of the center of pressure (COP) measured on the GymPlate (TechnoConcepts) | Confidence ellipse measured in millimeter² on force platform | 4 years | |
| Primary | Length covered by the consecutive center of pressure (COP) positions measured on the GymPlate (TechnoConcepts) | Length of the COP measured in millimeter on force platform | 4 years | |
| Primary | Mean velocity of the oscillations of the center of pressure (COP) measured on the GymPlate (TechnoConcepts) | Length of the COP measured in millimeter per second on force platform | 4 years | |
| Primary | Velocity variance measured on the GymPlate (TechnoConcepts) | Length of the COP measured in millimeter² per second² on force platform | 4 years | |
| Primary | Percent accuracy on the Corsi Block Test | Measure of visuospatial memory | 4 years | |
| Primary | Response time on the Corsi Block Test | Measure of visuospatial memory in milliseconds | 4 years | |
| Primary | Percentage of accuracy on the mental rotation task | Measure of mental rotation (visuospatial cognition) | 4 years | |
| Primary | Response time on the mental rotation task | Measure of mental rotation (visuospatial cognition) in milliseconds | 4 years | |
| Primary | Percentage of accuracy on the backward digit recall test | Measure of working memory | 4 years | |
| Primary | Response time on the backward digit recall test | Measure of working memory in milliseconds | 4 years | |
| Primary | Percentage of accuracy on the symbol digit modalities test | Measure of processing speed | 4 years | |
| Primary | Response time on the symbol digit modalities test | Measure of processing speed in milliseconds | 4 years | |
| Primary | Percentage of accuracy on the auditory Stroop task | Measure of response inhibition | 4 years | |
| Primary | Response time on the auditory Stroop task | Measure of response inhibition | 4 years | |
| Primary | Percentage of accuracy on the visual Stroop task | Measure of response inhibition | 4 years | |
| Primary | Response time on the visual Stroop task | Measure of response inhibition | 4 years |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02533739 -
Vestibular Disorder and Visuo-spatial Functions
|
N/A | |
| Completed |
NCT00271791 -
Prednisone Treatment for Vestibular Neuronitis
|
Phase 2 | |
| Recruiting |
NCT06332326 -
Investigation of the Efficacy of Non-Invasive Vagus Nerve Stimulation and Physiotherapy in Unilateral Vestibular Hypofunction Patients
|
N/A | |
| Completed |
NCT01483937 -
Evaluation of a Sensory Enrichment Multimodal Device (SEMD) on Physical Therapy Patients With Disequilibrium
|
N/A | |
| Recruiting |
NCT05634902 -
Implementation of Evidence-Based Practice for Dizziness
|
N/A | |
| Recruiting |
NCT05436067 -
Individualized Vestibular Rehabilitation for Elderly With Self-Management and Gaming Elements
|
N/A | |
| Completed |
NCT02753179 -
Covert-saccades, Dynamic Visual Acuity and Quality of Life
|
N/A | |
| Completed |
NCT03160352 -
Effects of Exergames on Vestibular Function in Healthy Community Dwellers.
|
N/A | |
| Completed |
NCT03887923 -
Vestibular Physical Therapy for People With Alzheimer Disease
|
N/A | |
| Terminated |
NCT01305278 -
The Efficacy of Balance Gaming as an Adjunct to Vestibular Rehabilitation Therapy
|
N/A | |
| Completed |
NCT03464214 -
The Effects of Local Vibration and Cervical Stabilization Exercises Applied on Neck Muscles on Balance in Healthy Individuals
|
N/A | |
| Recruiting |
NCT03799991 -
Vestibular Therapy in Alzheimer's Disease
|
N/A | |
| Completed |
NCT02722486 -
Use of a Vibrotactile Balance Belt System for Vestibular Rehabilitation in the Pediatric Population
|
N/A | |
| Not yet recruiting |
NCT06350669 -
App-supported Vestibular Rehabilitation (RCT)
|
N/A | |
| Recruiting |
NCT03716908 -
Genotype-phenotype Correlation Study of Presymptomatic and Symptomatic DFNA9 Patients
|
||
| Completed |
NCT00768378 -
Safety and Efficacy Study of BrainPort® Balance Device in Peripheral Vestibular Dysfunction.
|
N/A | |
| Withdrawn |
NCT03578354 -
4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine
|
Phase 2 | |
| Completed |
NCT00702832 -
Effect of Vestibular Rehabilitation - a Randomized Controlled Trial
|
N/A | |
| Recruiting |
NCT00146952 -
Use of a Vibrotactile Sensory Prosthesis in Patients With Postural Imbalance and Spatial Disorientation
|
Phase 1 | |
| Recruiting |
NCT05674786 -
Vestibular Implantation to Treat Adult-Onset Bilateral Vestibular Hypofunction
|
N/A |